These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. FTDP-17: 2-year follow-up of motor and cognitive features after autologous stem-cell transplantation. Larner AJ J Neuropsychiatry Clin Neurosci; 2012; 24(2):E1-2. PubMed ID: 22772676 [No Abstract] [Full Text] [Related]
49. Autologous hematopoietic cell transplantation for high-risk ALL. Linker C; Damon L; Martin T; Blume K; Forman S; Snyder D; Wolf J; Negrin R Bone Marrow Transplant; 2011 Mar; 46(3):460-1. PubMed ID: 20531287 [No Abstract] [Full Text] [Related]
50. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA; Sims-Poston L; Eldridge P; Hale GA Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921 [TBL] [Abstract][Full Text] [Related]
51. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Lakota J; Fuchsberger P Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035 [No Abstract] [Full Text] [Related]
52. New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients. Bruserud O; Tjønnfjord G; Gjertsen BT; Foss B; Ernst P Stem Cells; 2000; 18(5):343-51. PubMed ID: 11007918 [TBL] [Abstract][Full Text] [Related]
53. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526 [TBL] [Abstract][Full Text] [Related]
54. [Clinical significance of autologous transplantation with hematopoietic stem cells in leukemia and solid tumors]. Hinterberger W; Adler V; Bauer K; Haberhauer G; Habertheuer KH; Höniger S; Huber K; Kier P; Kittel E; Ruckser R Wien Med Wochenschr; 1995; 145(2-3):34-40. PubMed ID: 7762250 [TBL] [Abstract][Full Text] [Related]
55. Multiple myeloma in a 50-year-old with an HLA-identical sibling. Koreth J Biol Blood Marrow Transplant; 2007 Oct; 13(10):1247-8. PubMed ID: 17889363 [No Abstract] [Full Text] [Related]
56. Making the lame walk?: transplantation for POEMS. Chalk C Neurology; 2008 Nov; 71(21):1658-9. PubMed ID: 18832139 [No Abstract] [Full Text] [Related]
57. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593 [TBL] [Abstract][Full Text] [Related]
58. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703 [TBL] [Abstract][Full Text] [Related]
59. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation. Sanada S; Ookawara S; Karube H; Shindo T; Goto T; Nakamichi T; Saito M; Matsubara M; Suzuki M Am J Kidney Dis; 2006 Apr; 47(4):672-9. PubMed ID: 16564945 [TBL] [Abstract][Full Text] [Related]
60. Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma. Dietrich S; Tielesch B; Rieger M; Nickelsen M; Pott C; Witzens-Harig M; Kneba M; Schmitz N; Ho AD; Dreger P Cancer; 2011 May; 117(9):1901-10. PubMed ID: 21509767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]